[1] Rich N, Singal AG. Hepatocellular carcinoma tumour markers: current role and expectations. Best Pract Res Clin Gastroenterol, 2014, 28: 843-853.
[2] Schütte K,Bornschein J,Malfertheiner P.Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis,2009,27:80-92.
[3] European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol, 2009, 51: 237-267.
[4] Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol, 2006, 101: 513-523.
[5] Abelev GI, Perova SD, Khramkova NI, et al. Production of embryonic alpha-globulin by the transplantable mouse hepatomas.Transplantation,1963,1:174-80.
[6] Yu ST. Detection of embryospecific alpha-globulin in serum of patients with primary liver cancer. I-st All-Union Biochem Cong Abstr Book, 1963, 2: 274.
[7] Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest, 1956, 8: 174-174.
[8] Jia ZJ, Wang L,Liu C,et al.Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.Contemp Oncol, 2014,18: 192-196.
[9] Debruyne EN, Delanghe J R. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta,2008, 395: 19-26.
[10] 原发性肝癌诊疗规范,临床肿瘤学杂志. 2011,16: 929-946.
[11] Li D,Mallory T,Satomurs S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma.Clin Chim Acta.2001,313: 15-19.
[12] Choi JY, Jung SW, Kim HY, et al. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol, 2013, 19: 339-346.
[13] 王向臣,于传亭,曲建香,等.甲胎蛋白异质体AFP-L3鉴别良恶肝病及预警肝癌的研究.医学检验与临床,2011,22:64-66.
[14] Leerapun A, Suravarapu SV, Bida JP, et al. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol.,2007,5: 394-402.
[15] 詹爱霞,李强,祝光耀.AFP-L3在鉴别良恶性肝病中的作用.放射免疫学杂志,2010,23:88-89.
[16] Toyoda H, Kumada T, Tada T, et al. Clinical utility of highly sensitive Lens culinaris agglutinin‐reactive alpha‐fetoprotein in hepatocellular carcinoma patients with alpha‐fetoprotein<20 ng/mL. Cancer Sci,2011,102: 1025-1031.
[17] 李鲁平,谷海峰,陈霖,等.甲胎蛋白异质体L3对低浓度甲胎蛋白肝癌诊断的临床意义.中华实验和临床病毒学杂志,2013,27:452-454.
[18] Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgilocalized protein upregulated by viral infection. Gene, 2000, 249: 53-65.
[19] Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A, 2005, 102: 779-784.
[20] Marrero JA, Romano PR, Nikolaeva O,et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
[21] Mao Y,Yang H,Xu H,et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut, 2010,59:1687-1693.
[22] Willyard C. Researchers look for sweet method to diagnose cancer.Nat Med.2007,13:1267.
[23] 吕新华. 高尔基体73在肝癌诊断上的意义.肝脏,2012,17: 104-105.
[24] 杨盛力, 王云霞, 赵志辉, 等. 比较GP73和AFP联合检测与 AFP单项检测对原发性肝癌的诊断价值的meta分析. 肝胆外科杂志, 2012, 20: 251-255.
[25] 侯飞.AFP、AFP-L3、GP73联合检测在肝癌诊断中的应用.医学综述,2012,18:2919-20.
[26] 张红娟,吴侠,赵运胜,等.血清GP73联合AFP-L3和AFP检测在原发性肝癌诊断中的临床意义.中国医刊,2013,48:48-50.
[27] Hu B, Tian X, Sun J, et al. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma :a meta analysis, Int J Mol Sci,2013,14:23559-23580.
[28] 张华,李永兴,乐嫣,等. 血清GPC3、GP73和AFP联合检测 在HCC中的临床价值. 标记免疫分析与临床,2014,21:132-135.
[29] Xu WJ, Guo BL, Han YG, et al. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels. Tumour Biol, 2014, 35: 12069-12074.
[30] Shi M M, Huang ZX, Yang Y, et al. Diagnostic value of serum Golgi protein-73 (GP73) combined with AFP-L3% in hepatocellular carcinoma: a meta-analysis.Zhonghua Gan Zang Bing Za Zhi, 2015, 23: 189-193.
[31] Zhang Z, Zhang Y, Wang Y, et al. Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma. Onco Targets Ther, 2016, 9: 123. |
